PANORO ENERGY And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – PANORO ENERGY (PEN.OL), MELEXIS (MELE.BR), SEABIRD EXPLORAT (SBX.OL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. PANORO ENERGY (PEN.OL)

1541.6% sales growth and 16.05% return on equity

Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas properties in Africa. It holds assets in the Equatorial Guinea, Gabon, Tunisia, and South Africa. The company was incorporated in 2009 and is based in London, the United Kingdom.

Earnings Per Share

As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr3.13.

PE Ratio

PANORO ENERGY has a trailing twelve months price to earnings ratio of 8.28. Meaning, the purchaser of the share is investing kr8.28 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.05%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 236.15M for the twelve trailing months.

Yearly Top and Bottom Value

PANORO ENERGY’s stock is valued at kr25.92 at 06:20 EST, way under its 52-week high of kr32.88 and above its 52-week low of kr24.08.

Earnings Before Interest, Taxes, Depreciation, and Amortization

PANORO ENERGY’s EBITDA is 64.9.

More news about PANORO ENERGY.

2. MELEXIS (MELE.BR)

7.2% sales growth and 40.81% return on equity

Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN transceiver, CAN transceiver, RFID Transceiver NFC Sensor tag ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.

Earnings Per Share

As for profitability, MELEXIS has a trailing twelve months EPS of €5.24.

PE Ratio

MELEXIS has a trailing twelve months price to earnings ratio of 15.22. Meaning, the purchaser of the share is investing €15.22 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.81%.

Yearly Top and Bottom Value

MELEXIS’s stock is valued at €79.75 at 06:20 EST, way under its 52-week high of €106.90 and way above its 52-week low of €67.50.

More news about MELEXIS.

3. SEABIRD EXPLORAT (SBX.OL)

7.1% sales growth and 21.51% return on equity

SeaBird Exploration Plc, together with its subsidiaries, provides marine 2D and 3D seismic data for the oil and gas industry in Europe, Africa, the Middle East, North and South America, and the Asia Pacific. It offers 2D seismic; and source vessels that provide conventional undershoot, 4D repeat survey, wide azimuth, push reverse, long-term charter and vessel management, in-house source modelling and environmental decay analysis, and spot charter services. The company was founded in 1996 and is based in Nicosia, Cyprus.

Earnings Per Share

As for profitability, SEABIRD EXPLORAT has a trailing twelve months EPS of kr0.32.

PE Ratio

SEABIRD EXPLORAT has a trailing twelve months price to earnings ratio of 14.48. Meaning, the purchaser of the share is investing kr14.48 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.51%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 147.6% and 477.8%, respectively.

Yearly Top and Bottom Value

SEABIRD EXPLORAT’s stock is valued at kr4.64 at 06:20 EST, way below its 52-week high of kr6.00 and way above its 52-week low of kr3.40.

Revenue Growth

Year-on-year quarterly revenue growth grew by 137.2%, now sitting on 35.05M for the twelve trailing months.

More news about SEABIRD EXPLORAT.

4. VISTIN PHARMA (VISTN.OL)

6.6% sales growth and 16.03% return on equity

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, VISTIN PHARMA has a trailing twelve months EPS of kr1.

PE Ratio

VISTIN PHARMA has a trailing twelve months price to earnings ratio of 23.7. Meaning, the purchaser of the share is investing kr23.7 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.03%.

Sales Growth

VISTIN PHARMA’s sales growth is 10.6% for the present quarter and 6.6% for the next.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Jan 23, 2024, the estimated forward annual dividend rate is 0.75 and the estimated forward annual dividend yield is 3.13%.

Volume

Today’s last reported volume for VISTIN PHARMA is 1565 which is 88.82% below its average volume of 14002.

More news about VISTIN PHARMA.

Leave a Reply

Your email address will not be published. Required fields are marked *